DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.3 EUR | -1.52% |
|
+7.08% | -29.69% |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.32
EUR
Average target price
4.733
EUR
Spread / Average Target
+258.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.69% | 138M | |
| +14.99% | 78.65B | |
| +9.32% | 8.94B | |
| -12.05% | 5.16B | |
| +53.66% | 4.85B | |
| +11.63% | 4.19B | |
| -23.67% | 2.32B | |
| +12.07% | 2.29B | |
| -32.35% | 2.19B | |
| +21.04% | 2.19B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies
